Johnson & Johnson
Canvas Category OEM : Pharmaceutical
Johnson & Johnson Innovation seeks to positively impact human health through innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve people’s lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success.
Assembly Line
Merck Teams Up With Rival J&J to Help Produce Its Covid Vaccine
Johnson & Johnson Announces Plans to Separate Consumer Health Business
Johnson & Johnson announced its intent to separate the Company’s Consumer Health business, creating a new publicly traded company. The planned separation would create two global leaders that are better positioned to deliver improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth.
Announcing the Microsoft Cloud for Manufacturing preview
The Microsoft Cloud for Manufacturing brings the best outcome-driven solutions and capabilities from Microsoft and our partners to accelerate time-to-value for our customers in an end-to-end, holistic, and scalable way. By connecting intelligent, integrated cloud, and edge capabilities of the Microsoft stack to the highest value manufacturing scenarios, we are creating a flywheel of innovation that helps businesses increase asset and frontline worker productivity in safe and secure factories, enable remote selling and always-on service, and unlock cloud-based innovation—all with the utmost trust, compliance, privacy, and transparency.
I am particularly excited about how we are integrating Microsoft Teams frontline workers and mixed reality across these capabilities. This will increase productivity in hybrid work scenarios, and allow insights from securely connected IoT assets and products to be integrated into workflows and business processes in Microsoft Dynamics 365 Business Applications and partner solutions.
Global Lighthouse Network: Unlocking Sustainability through Fourth Industrial Revolution Technologies
The Global Lighthouse Network is a community of production sites and other facilities that are world leaders in the adoption and integration of the cutting-edge technologies of the Fourth Industrial Revolution (4IR). Lighthouses apply 4IR technologies such as artificial intelligence, 3D-printing and big data analytics to maximize efficiency and competitiveness at scale, transform business models and drive economic growth, while augmenting the workforce, protecting the environment and contributing to a learning journey for all-sized manufacturers across all geographies and industries.
Why We Can't Make Vaccine Doses Any Faster
The Trump administration deployed the Defense Production Act last year to give vaccine manufacturers priority in accessing crucial production supplies before anyone else could buy them. And the Biden administration used it to help Pfizer obtain specialized needles that can squeeze a sixth dose from the company’s vials, as well as for two critical manufacturing components: filling pumps and tangential flow filtration units. The pumps help supply the lipid nanoparticles that hold and protect the mRNA — the vaccines’ active ingredient, so to speak — and also fill vials with finished vaccine. The filtration units remove unneeded solutions and other materials used in the manufacturing process.
These highly precise pieces of equipment are not typically available on demand, said Matthew Johnson, senior director of product management at Duke University’s Human Vaccine Institute, who works on developing mRNA vaccines, but not for COVID-19. “Right now, there is so much growth in biopharmaceuticals, plus the pinch of the pandemic,” he said. “Many equipment suppliers are sold out of production, and even products scheduled to be made, in some cases, sold out for a year or so looking forward.”
'It'll never be fast enough': 5 questions for a ventilator manufacturer
Making more ventilators in time to help coronavirus victims is hard enough. But what about manufacturing the sophisticated equipment needed to clinically test them? Or hospital beds for the patients using them?